BG Medicine , Nasdaq: BGMD
Markets a biomarker diagnostic test for heart failure and is developing others.
Industry: Health Care
First Day Return: +15.0%
BGMD
Markets a biomarker diagnostic test for heart failure and is developing others.
| IPO Data | |
|---|---|
| IPO Date | 02/03/2011 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $35 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Waltham, MA, United States |
| Founded | 2000 |
| Employees at IPO | 51 |
| Website www.bg-medicine.com | |
IPO News for BG Medicine
BG Medicine (BGMD) Performance
